NRXS
NeurAxis, Inc.
Industry
Biotechnology
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Loading...
Open
2.60
Mkt cap
17M
Volume
27K
High
2.77
P/E Ratio
-6.05
52-wk high
3.89
Low
2.48
Div yield
N/A
52-wk low
2.00

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.